Biogen Inc. announced the European Commission (EC) has authorized Skyclarys (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. Skyclarys is the first treatment approved within the...
Numab Therapeutics AG, an organization creating multi-explicit antibody-based immunotherapies for irritation and cancer disease, and Osaka-settled Research and development situated drug organization, Ono Pharma, both mutually declared a worldwide...
Boehringer Ingelheim's (BI) said its diabetes drug Jardiance (empagliflozin) 10mg measurements structure has now been approved by the Focal Medications Standard Control Association of India for the therapy of ongoing kidney illness (CKD), as an...
Curasight A/S, a clinical development company based in Copenhagen, Denmark, announced that it is accelerating and expanding its clinical treatment strategy by adding new Phase 1/2a trials covering five cancer symptoms
DelSiTech Ltd., a pharmaceutical development and supply company, and Tolmar International Ltd., a fully integrated pharmaceutical company, have strengthened their partnership by signing a global licensing and development agreement following Tolmar's
Torus Health has partnered with Tata 1mg to create a unique new solution in the healthcare industry. An innovative initiative by Torus Group, a subsidiary of Cosmea Financial Holdings Pvt Ltd, is about to revolutionize India's health and wellness
The Indian Pediatric Association (IAP) has launched a pioneering program called 'IAP Ki Baat, Community Ke Saath' to engage the community actively and provide valuable information on child health.
World Health Organization, drug market
Roche announced that it has signed an agreement with PathAI, a world leader in artificial intelligence (AI)-based pathology technologies.
Eris Lifesciences Ltd., an Indian marked plans organization, reported the extension of its Sterile Injectables impression through the securing of 51% value stake in Swiss Parenterals Ltd. for a thought of Rs.637.50 crore. As per a press...
, CDSCO.jpg)
